Zogenix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Zogenix and buy or sell other stocks, ETFs, and their options commission-free!About ZGNX
Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders.
CEOIris Löw-Friedrich, MD, PhD
CEOIris Löw-Friedrich, MD, PhD
Employees—
Employees—
HeadquartersEmeryville, California
HeadquartersEmeryville, California
Founded2006
Founded2006
Employees—
Employees—
ZGNX Key Statistics
Market cap1.50B
Market cap1.50B
Price-Earnings ratio-6.55
Price-Earnings ratio-6.55
Dividend yield—
Dividend yield—
Average volume3.46M
Average volume3.46M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$26.90
52 Week high$26.90
52 Week low$11.03
52 Week low$11.03
Stock Snapshot
The current Zogenix(ZGNX) stock price is $26.68, with a market capitalization of 1.5B. The stock trades at a price-to-earnings (P/E) ratio of -6.55.
On 2025-12-17, Zogenix(ZGNX) stock opened at —, reached a high of —, and a low of —.
The Zogenix(ZGNX)'s current trading volume is 0, compared to an average daily volume of 3.46M.
During the past year, Zogenix(ZGNX) stock moved between $11.03 at its lowest and $26.90 at its peak.
During the past year, Zogenix(ZGNX) stock moved between $11.03 at its lowest and $26.90 at its peak.
People also own
Based on the portfolios of people who own ZGNX. This list is generated using Robinhood data, and it’s not a recommendation.